PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2111507
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2111507
Structural Heart Imaging Market size was valued at USD 10,500.8 Million in 2025, expanding to a CAGR of 6.1% from 2026 to 2033.
Structural heart imaging refers to the use of advanced diagnostic imaging technologies to visualize the heart's valves, chambers, blood vessels, and surrounding anatomical structures, enabling accurate diagnosis, treatment planning, and ongoing monitoring of structural heart diseases. It plays a vital role in supporting minimally invasive and catheter-based cardiac procedures, including transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (TMVR), and other structural heart interventions by providing precise anatomical assessment.
Structural Heart Imaging Market- Market Dynamics
Increasing prevalence of valvular heart disorders, cardiac abnormalities and need for minimally invasive heart procedures are expected to propel market demand
The structural heart imaging market is mainly driven by the rising prevalence of valvular heart diseases, congenital heart defects, and other structural cardiac abnormalities across the globe. The increasing incidence of age-related cardiovascular conditions, particularly among the expanding geriatric population, has significantly increased the demand for advanced imaging technologies capable of accurately assessing complex heart structures. According to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of mortality globally, constituting for millions of deaths every year. This growing disease burden is prompting healthcare providers to adopt advanced structural heart imaging modalities, including echocardiography, cardiac computed tomography (CT), cardiac magnetic resonance imaging (MRI), and fluoroscopic imaging, to advance diagnostic accuracy and procedural outcomes.
The increasing adoption of minimally invasive and catheter-based structural heart interventions is a major factor driving the growth of the structural heart imaging market. Procedures such as transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair or replacement (TMVR), left atrial appendage closure (LAAC), and transcatheter tricuspid valve interventions rely heavily on high-resolution, real-time imaging for accurate pre-procedural planning, and procedural evaluation. In addition, ongoing advancements in three-dimensional (3D) echocardiography, cardiac computed tomography (CT), cardiac magnetic resonance imaging (MRI) is also fueling market growth. Advanced imaging technologies enable clinicians to visualize complex cardiac anatomy with greater accuracy, reducing procedural risks and improving treatment outcomes. As healthcare providers continue to shift toward less invasive treatment approaches that offer shorter hospital stays, faster recovery, and improved patient outcomes, the demand for sophisticated structural heart imaging systems is expected to grow over the forecast period.
The Global Structural Heart Imaging Market is segmented on the basis of Imaging Modality, Technology, Application, End User, and Region.
The market is divided into five categories based on Imaging Modality: Echocardiography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Fluoroscopy, and others. The Echocardiography segment constitute significant share of the structural heart imaging market due to its widespread clinical use. It serves as the primary imaging modality for diagnosing structural heart diseases and supporting interventional procedures such as TAVR and mitral valve repair.
Structural Heart Imaging Market- Geographical Insights
North America holds the substantial share of the structural heart imaging market, driven by its well-established healthcare infrastructure, widespread adoption of advanced cardiac imaging technologies, and high volume of minimally invasive structural heart procedures. The region benefits from the strong presence of leading medical device and imaging companies. Europe represents a significant share of the global structural heart imaging market. Due to its rapidly aging population and rising incidence of valvular heart disorders, Europe accounts for a sizeable portion of the worldwide structural heart imaging market. Germany, France, and the UK are among the nations making significant investments in cutting-edge cardiac imaging technology. Asia Pacific is anticipated to rise quickly due to rising investments in medical imaging infrastructure and increased awareness of early detection.
Italy Structural Heart Imaging Market- Key Insights
Italy gradually emerging as a promising market for structural heart imaging due to improving cardiovascular healthcare services and growing investments in advanced diagnostic technologies. Rising incidence of cardiovascular diseases, expanding private healthcare infrastructure, and increasing availability of specialized cardiac centers are supporting demand for modern imaging systems. Growing awareness of minimally invasive cardiac procedures and ongoing modernization of hospital facilities are expected to contribute to continued market growth.
The structural heart imaging market is highly competitive, with leading medical imaging companies focusing on continuous innovation, artificial intelligence (AI) integration, and the expansion of their cardiovascular imaging portfolios. Market participants are investing significantly in next-generation echocardiography, cardiac computed tomography (CT), magnetic resonance imaging (MRI), intracardiac imaging, and fusion imaging technologies to enhance diagnostic precision, improve workflow efficiency, and support image-guided structural heart interventions. Additionally, companies are focusing on integrated imaging systems that offer smooth assistance at every stage of the patient care process, from diagnosis and procedure planning to intra-procedural guidance and follow-up after treatment. Moreover, innovation is being accelerated by strategic partnerships between hospitals, research institutes, cardiovascular device makers, and medical imaging firms.
In March 2025, GE HealthCare expanded its structural heart imaging portfolio by advancing its AI-enabled echocardiography solutions with automated cardiac measurements, enhanced image analysis, and intelligent workflow optimization to improve the accuracy and efficiency of structural heart disease assessment.
In June 2025, Philips strengthened its structural heart imaging portfolio by enhancing its EchoNavigator platform with advanced fusion imaging capabilities, delivering improved real-time visualization and procedural guidance to support transcatheter valve interventions.